BioXell Listed by Tornado Insider as One of Europe's Top 100 Start-Ups
July 18, 2002 06:13 ET
|
BioXell SpA
MILAN, Italy, July 18, 2002 (PRIMEZONE) -- July 2002 BioXell S.p.A. was recently named in the second annual "Tornado Insider 100" list as one of Europe's top emerging private tech companies. BioXell,...
Milestone Reached in the Karo Bio - Merck & CO., Inc. Collaboration
July 17, 2002 05:49 ET
|
Karo Bio
HUDDINGE, Sweden, July 17, 2002 (PRIMEZONE) -- A significant preclinical milestone has been achieved in the estrogen receptor collaboration between Merck & Co., Inc and Karo Bio. The event is...
BioXell Appoints Dr. Bernd Seizinger to Board of Directors
July 02, 2002 07:20 ET
|
BioXell SpA
MILAN, Italy, July 2, 2002 (PRIMEZONE) -- BioXell SpA, the Italian biopharmaceutical company focused on immunology, today announced the appointment of Professor Bernd Seizinger to the Board of...
Women First HealthCare Acquires VANIQA From Bristol-Myers Squibb Company and The Gillette Company
June 25, 2002 18:58 ET
|
Women First HealthCare, Inc.
SAN DIEGO, June 25, 2002 (PRIMEZONE) -- Women First HealthCare, Inc. (Nasdaq:WFHC) announced today that it acquired exclusive worldwide rights and title to VANIQA(r) (eflornithine hydrochloride)...
Astex Announces Structure-Based Drug Discovery Agreement with Mitsubishi Pharma Corporation
June 10, 2002 05:40 ET
|
Astex Therapeutics
CAMBRIDGE, U.K., June 10, 2002 (PRIMEZONE) -- Astex Technology, the U.K. structure-based drug discovery company today announced a structural biology research agreement with Mitsubishi Pharma...
Amersham Health Receives Approval to Market Optison Ultrasound Diagnostic in Europe
June 06, 2002 04:54 ET
|
Amersham plc
LONDON, June 6, 2002 (PRIMEZONE) -- Amersham Health, a global leader in medical diagnostic imaging and a business of Amersham plc (LSE:AHM) (NYSE:AHM) (OSE:AHM), has obtained EU marketing...
Robin Brown Joins Galapagos Genomics as Chief Scientific Officer
May 21, 2002 07:52 ET
|
Galapagos Genomics
MECHELEN, Belgium, May 21, 2002 (PRIMEZONE) -- Galapagos Genomics NV today announced that Robin Brown has been appointed Chief Scientific Officer (CSO). Dr. Brown will be responsible for directing...
Biacore: Annual General Meeting, May 7, 2002
May 08, 2002 03:44 ET
|
Biacore
UPPSALA, Sweden, May 08, 2002 (PRIMEZONE) -- Biacore International AB (Biacore) (SSE:BCOR) (Nasdaq:BCOR) today announced that today's Annual General Meeting was attended by 30 shareholders,...
Q-Med: Clinical Study in the U.S.A Showed Clearly Significant Results in Favour of RESTYLANE.
May 06, 2002 04:28 ET
|
Q-Med
UPPSALA, Sweden, May 6, 2002 (PRIMEZONE) -- In the clinical study in the USA where the Swedish company Q-Med's* product RESTYLANE has been compared with a competing collagen-based product, the effect...
Trigen Builds Internal Cardiovascular Discovery Capability; Tri Drug Discovery Group Integrated into Trigen
May 02, 2002 03:35 ET
|
Trigen
LONDON, May 2, 2002 (PRIMEZONE) -- Trigen Ltd. announced today that it has transferred the Drug Discovery Group ("DDG") of the Thrombosis Research Institute ("TRI") to its own operations.
The...